Tag: cancer
Phase III Front-line Trial Planned with Brentuximab Vedotin in Advanced Stage...
Interim results from a phase I clinical trial of brentuximab vedotin(SGN-35, Adcetris™, Seattle Genetics/Millennium: The Takeda Oncology Company) in combination with chemotherapy for the...
Data on Brentuximab Vedotin Highlights Positive Findings and Clinically Meaningful Durations...
Data reported today demonstrating that prolonged treatment with Brentuximab Vedotin (SGN-35; Adcetris™, Seattle Genetics) beyond 16 cycles of therapy was associated with clinically meaningful...
Novel Drugs Breaks Down Barriers – Attacks Breast Cancer Cells from...
Throwing stones at castle walls is one way to attack an enemy, but sneaking inside makes the target much more vulnerable. Researchers at Cedars-Sinai's...
Sanofi-Aventis In-licenses Therapeutic Antibody for the Treatment of Solid Cancers From...
Earlier this month French pharmaceutical giant Sanofi-aventis acquired an exclusive world-wide license to one of Oxford BioTherapeutics’ internal preclinical antibody programs. Sanofi-aventis intends to...
Investigational Antibody-Drug Conjugate, Shows Encouraging Results in Women With Highly Advanced...
Results of a Phase II study of trastuzumab (Herceptin®, Genentech) in combination with DM1 (T-DM1), an investigational HER2 antibody-drug conjugate being developed by Genentech,...
